Asthma Society of Canada
The Asthma Society of Canada seeks to empower every child and adult in Canada with asthma to live an active and symptom-free life. Their mission is to be the balanced voice for asthma in Canada, advancing optimal self-management, prevention, research and health care.
During 2016, GSK funded Asthma Society of Canada with:
- $75,000 in core funding to support advocacy initiatives and stakeholder consultations
- $60,000 in project funding for Severe Asthma: The Canadian Patient Journey
- $20,000 in conference sponsorship
GSK’s contributions represent 15.5% of the organization’s total revenue for 2016.